Hoechst bolsters drugs division
15 Jan 2000
The `vast majority' of Roussel Uclaf's shareholders have accepted Hoechst's offer to buy their shares, according to French stock exchange authorities, giving the German firm a 99 per cent stake in the drugs company. This gives Hoechst `the necessary leeway to create an integrated global pharmaceutical company,' it comments.
